Natco Pharma net rises 12%
Natco Pharma net profit increased 11.85 per cent at 217 crore in the third quarter ended December 31, 2017, against 194 crore in the corresponding quarter of the previous year. Total revenue, how06-02-2018
06-02-2018
Press Release / Media Release
NATCO records INR 573.6 Crore revenue and INR 217.4 Crore of Profit, after tax, for the Third Quarter, For the year 2017-1806-02-2018
Board declares Second Interim Dividend
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at their meeting held on February 06, 2018, inter alia, have declared second interim dividend of Rs. 7/- (Rupees seven only) on each equity share of Rs. 2/- (Rupees two only) each for the year 2017-18 (which is 350% on the nominal value of the share). The payment of said interim dividend will start from February 22, 2018.06-02-2018
Record Date For Payment Of Second Interim Dividend 17Th February, 2018
Record Date for payment of Second Interim Dividend 17th February, 201806-02-2018
Board to consider Q3 results & Second Interim Dividend on Feb 06, 2018
Natco Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on February 06, 2018, inter alia, to consider the following items of business:1. The unaudited financial Results for the quarter and nine months ended December 31, 2017 (Q3) and related matters.2. To consider Second Interim Dividend, if any, for the financial year 2017-18 and related matters etc....29-01-2018
Closure of Trading Window
Trading Window of the company will be closed from 29th January, 2018 to 8th February, 2018 and will be opened from 9th February, 201829-01-2018
Board Meeting On 6,FEB, 2018
to consider un audited Financial Results for the quarter and nine months ended 31st December, 201729-01-2018
Allotment of ESOP / ESPS
Compensation committee of the Board of Directors of the Company held today has approved and allotted 8100 equity shares of Rs.2/- under Employee Stock Option Scheme NATSOP201622-01-2018